Short answer
LifeMD, Inc. (LFMD) filed an 8-K current report with the SEC on March 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 2025 and full-year 2025 financial results announced March 9, 2026.
LifeMD, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 2025 and full-year 2025 financial results announced March 9, 2026
- 2026 earnings guidance also disclosed: key forward-looking signal for investors
- Full details in Exhibit 99.1 press release
Item 7.01 · Regulation FD Disclosure
- Investor presentation filed as Exhibit 99.2, in use starting March 9, 2026: check exhibit for strategic/financial details
- Presentation covers projected industry growth rates, company growth rates, and cash flow positioning per forward-looking statements disclosure
- Filed under Reg FD (not "filed" for Exchange Act purposes), meaning no legal liability attached but content reflects what management is telling investors now
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeMD, Inc. 8-K filings
Get the next LFMD 8-K as it lands
Follow LFMD for push alerts, or ask the research agent what this filing means.